Titration of Long-Acting Insulin Using Continuous Glucose Monitoring and Smart Insulin Pens in Type 1 Diabetes: A Model-Based Carbohydrate-Free Approach
出版年份 2022 全文链接
标题
Titration of Long-Acting Insulin Using Continuous Glucose Monitoring and Smart Insulin Pens in Type 1 Diabetes: A Model-Based Carbohydrate-Free Approach
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-01-10
DOI
10.3389/fendo.2021.795895
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Pilot Non-Inferiority Randomized Controlled Trial to Assess Automatic Adjustments of Insulin Doses in Adolescents with Type 1 Diabetes on Multiple Daily Injections Therapy
- (2020) Anas El Fathi et al. PEDIATRIC DIABETES
- Mapping data to virtual patients in type 1 diabetes
- (2020) Patricio Colmegna et al. CONTROL ENGINEERING PRACTICE
- Safety and feasibility of the PEPPER adaptive bolus advisor and safety system; a randomized control study
- (2020) Parizad Avari et al. Diabetes Technology & Therapeutics
- Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes
- (2020) Revital Nimri et al. NATURE MEDICINE
- The SAGE study: global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM
- (2020) Eric Renard et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Using Iterative Learning for Insulin Dosage Optimization in Multiple-Daily-Injections Therapy for People With Type 1 Diabetes
- (2020) Marzia Cescon et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- A Model-Based Insulin Dose Optimization Algorithm for People With Type 1 Diabetes on Multiple Daily Injections Therapy
- (2020) Anas El Fathi et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
- (2019) Nicole C. Foster et al. Diabetes Technology & Therapeutics
- A Century of Diabetes Technology: Signals, Models, and Artificial Pancreas Control
- (2019) Boris Kovatchev TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies
- (2019) Roberto Visentin et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes
- (2019) Michele Schiavon et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Technology in the management of type 1 diabetes mellitus — current status and future prospects
- (2018) Martin Tauschmann et al. Nature Reviews Endocrinology
- New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)
- (2015) Philip D. Home et al. DIABETES CARE
- Model of glucose sensor error components: identification and assessment for new Dexcom G4 generation devices
- (2014) Andrea Facchinetti et al. MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING
- Glycemic Control and Excess Mortality in Type 1 Diabetes
- (2014) Marcus Lind et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis and Classification of Diabetes Mellitus
- (2013) DIABETES CARE
- Carbohydrate counting accuracy and blood glucose variability in adults with type 1 diabetes
- (2012) A.S. Brazeau et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A run-to-run control strategy to adjust basal insulin infusion rates in type 1 diabetes
- (2007) Cesar C. Palerm et al. JOURNAL OF PROCESS CONTROL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started